Award
Delivery Order #SPE2DR26FF3E8
Delivery Order for Ondansetron Tablets under Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$2,854.79
Ceiling
$2,854.79
Awarded
February 13, 2026
Period of Performance
Feb 13, 2026 – Feb 17, 2026
Identifier
SPE2DR26FF3E8
NAICS
424210
This contract award is a delivery order contract executed under a broader indefinite delivery vehicle (IDV) with AmerisourceBergen Drug Corp, a leading pharmaceutical distributor. The award involves the procurement of Ondansetron ODT 4 mg tablets, a medication commonly used to prevent nausea and vomiting caused by chemotherapy. This delivery order supports the agency’s ongoing pharmaceutical supply needs and ensures timely access to essential medications. The scope of work specifically includes the delivery of the Ondansetron tablets within a short-term performance window. The delivery order was issued as part of a multi-year IDV contract awarded to AmerisourceBergen, highlighting a sustained partnership for pharmaceutical services. This procurement appears to be executed under a competitive contract vehicle previously awarded to AmerisourceBergen, leveraging their extensive distribution capabilities. The contract period is brief, illustrating a specific, immediate need fulfillment, with the order to be performed in Conshohocken, PA. There is no indication of sole-source justification, suggesting this delivery order follows established contract terms within the IDV framework. The parent IDV contract reinforces this award’s significance by providing a stable supply chain foundation for pharmaceuticals over many years, impacting both healthcare providers and patient care continuity.
Description
4570834611!ONDANSETRON ODT 4 MG TABLET 30S